Health knowledge made personal
Join this community!
› Share page:
Search posts:

FDA Approves New Late Stage Breast Cancer Drug From Roche, Life Extending Kadcyla

Posted Feb 23 2013 8:48pm
imageTDM-1 was the name given to the drug during the clinical trial.  One thing that’s not any different is the price of another life extending drug, about $9800 a month and will be available in a couple of weeks.  Kadcyla is a combination of a current cancer drug, Herceptin and a chemotherapy drug named DM-1.  It is to be prescribed when Herceptin is no longer effective on it’s own.  DM-1 on it’s own is way too toxic to delivery into the bloodstream alone.  A normal course of treatment is about 9  months so you can do the math here to see at the price listed above, it is expensive.  Of course they do have a hardship program where some might be able to get the drug for free.  BD

Post a comment
Write a comment: